Phase 2 Start~month

Phase 2 Start: A Phase IIa, Single-arm, Single-center, Open Label, Proof-of-concept Trial Evaluating Increased Freq

Drug
increased
Indication
Pancreas Cancer, Metastatic; Pancreas Cancer, Stage IV; Ductal Adenocarcinoma of the Pancreas

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

  • 200 free AI credits / month to run live multi-agent analysis
  • Watchlist, catalyst alerts & the biotech event calendar
  • Full pipeline, financials & FDA data on every company
Start Free
    Phase 2 Start: A Phase IIa, Single-arm, Single-center, Open Label, Proof-of-concept Trial Evaluating Increased Freq — TOVX Phase 2 Start | BioSniper